In vitro metabolism of trazodone by CYP3A: inhibition by ketoconazole and human immunodeficiency viral protease inhibitors
- 1 April 2000
- journal article
- Published by Elsevier in Biological Psychiatry
- Vol. 47 (7) , 655-661
- https://doi.org/10.1016/s0006-3223(99)00176-6
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Antiretroviral Therapy for HIV Infection in 1998JAMA, 1998
- Antiretroviral therapy for patients with HIV diseaseBritish Journal of Clinical Pharmacology, 1998
- Differential inhibition of cytochrome P450 isoforms by the protease inhibitors, ritonavir, saquinavir and indinavirBritish Journal of Clinical Pharmacology, 1997
- Use of In Vitro and In Vivo Data to Estimate the Likelihood of Metabolic Pharmacokinetic InteractionsClinical Pharmacokinetics, 1997
- Protease Inhibitors in Patients with HIV DiseaseClinical Pharmacokinetics, 1997
- Xenobiotic-metabolizing human cells as tools for pharmacological and toxicological researchPublished by Elsevier ,1995
- Oral Azole Drugs as Systemic Antifungal TherapyNew England Journal of Medicine, 1994
- Psychotropic Medications in Oncology and in AIDS PatientsPublished by S. Karger AG ,1993
- Fatigue, sleep disturbance, disability, and indices of progression of HIV infectionAmerican Journal of Psychiatry, 1992
- TrazodoneDrugs, 1981